Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/1993
11/03/1993EP0567566A1 Methods for treating tumor necrosis factor mediated diseases
11/03/1993EP0567512A1 Sperm cell surface protein ph-20. use in a contraceptive vaccine
11/03/1993EP0567470A1 Pseudomonas peptide composition and method for producing the same
11/03/1993EP0567450A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same
11/03/1993EP0477198B1 Method for recovering recombinant proteins
11/03/1993CN1077991A Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5
11/02/1993US5258504 Process for the purification of streptolysin O, intact streptolysin O obtainable by this process
11/02/1993US5258498 Targeted multifunctional proteins, immunological treatment of cancer and infection
11/02/1993US5258497 Process for purifying annexines
11/02/1993US5258496 Precipitation and extraction of proteins
11/02/1993US5258288 DNA sequences and genetic vectors
11/02/1993US5258287 DNA sequences and hybrids
11/02/1993CA2094987A1 Human glutamate receptor proteins and associated dna compounds
11/02/1993CA1323851C Expression of human proapolipoprotein a-i
11/02/1993CA1323850C Kluyveromyces as a host strain
10/1993
10/30/1993CA2095060A1 Enzymatic reactions and apparatus for carrying them out
10/28/1993WO1993021526A1 METHODS AND COMPOSITIONS FOR MONITORING CELLULAR PROCESSING OF β-AMYLOID PRECURSOR PROTEIN
10/28/1993WO1993021347A1 Transcription control element for increasing gene expression in myoblasts
10/28/1993WO1993021337A1 Gustducin materials and methods
10/28/1993WO1993021331A2 Polysaccharide binding fusion proteins and conjugates
10/28/1993WO1993021328A1 Polypeptides having kinase activity, their preparation and use
10/28/1993WO1993021325A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor
10/28/1993WO1993021321A2 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA)
10/28/1993WO1993021320A1 Oil-body proteins as carriers of high-value peptides in plants
10/28/1993WO1993021319A1 HUMANIZED C-erbB-2 SPECIFIC ANTIBODIES
10/28/1993WO1993021318A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
10/28/1993WO1993021317A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN β SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E
10/28/1993WO1993021316A1 Mammalian melanocyte stimulating hormone receptors and uses
10/28/1993WO1993021315A1 Mammalian adrenocorticotropic hormone receptors and uses
10/28/1993WO1993021314A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization
10/28/1993WO1993021303A2 Enhanced purification and expression of insoluble recombinant proteins
10/28/1993WO1993021302A1 Cadherin materials and methods
10/28/1993WO1993021232A1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/neu) RELATED SURFACE ANTIGENS
10/28/1993WO1993021230A1 Activation-state-specific phosphoprotein immunodetection
10/28/1993WO1993021226A1 Cartilage matrix protein and methods for use
10/28/1993WO1993021220A1 Synthetic peptides useful in a vaccine against and in the diagnosis of streptococcal infection
10/28/1993WO1993021218A1 Synthetic polypeptides derived from the hiv envelope glycoprotein
10/28/1993WO1993021207A1 Process for making vancomycin
10/28/1993WO1993020852A2 Macrocyclic chelating agents, chelates and conjugates thereof
10/28/1993WO1993020848A1 Immunotoxins directed against cd33 related surface antigens
10/28/1993WO1993020843A1 Oral treatment of helicobacter infection
10/28/1993WO1993020841A1 Antibodies specific for carcinoma-associated antigens
10/28/1993WO1993019089A3 Oxygen carrier
10/28/1993WO1993014206A3 Synthetic peptides for a rubella vaccine
10/28/1993WO1993013196A3 Method for increasing recombinant protein production
10/28/1993CA2133739A1 Immunotoxins directed against c-erbb-2 (her-2/neu) related surface antigens
10/28/1993CA2133566A1 Transcription control element for increasing gene expression by myoblasts
10/28/1993CA2133339A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor
10/28/1993CA2131166A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization
10/28/1993CA2118033A1 Synthetic polypeptides derived from the hiv envelope gylcoprotein
10/28/1993CA2117887A1 Polysaccharide binding fusion proteins and conjugates
10/28/1993CA2117780A1 Cartillage matrix protein and methods for use
10/28/1993CA2117779A1 T cell epitopes of the major allergens from ambrosia artemisifolia
10/28/1993CA2117775A1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof
10/28/1993CA2111189A1 Oral treatment of helicobacter infection
10/27/1993EP0567311A2 Hydrocolloid wound gel
10/27/1993EP0566877A2 Enzymatic hydrolysis of proteines
10/27/1993EP0566824A1 Enzymatic peptide synthesis
10/27/1993EP0566714A1 Coupled transcription and translation in eukaryotic cell-free extract.
10/27/1993EP0566673A1 Biosynthetic pdgf antagonists
10/27/1993EP0566647A1 Improved humanized immunoglobulins
10/27/1993EP0566611A1 Analogs of piscine lhrh
10/27/1993EP0566579A1 Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and compositions
10/26/1993US5256770 Oxidation resistant thrombomodulin analogs
10/26/1993US5256642 Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
10/26/1993US5256561 Monoclonal antibody to HIV-2 and uses thereof
10/26/1993US5256548 A culture product of ACTINOMADURA PARVOSATA
10/26/1993US5256547 From strains of tolypocladium and sesquicillipsis; filtering, extraction, chromatographic purification
10/26/1993CA1323728C Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody
10/26/1993CA1323567C Method for purification of antibodies
10/21/1993CA2093735A1 Amyloid precursor-like protein and uses thereof
10/20/1993EP0566554A2 Production of recombinant proteins using herpes virus promoters and VP16 transactivators
10/20/1993EP0566410A2 Derivatives of adipogenesis inhibitory factor, their preparation and their use
10/20/1993EP0566158A1 The use of alpha-1-antitrypsin mutants in the manufacture of medicaments, and therapeutic formulations using mutants and their preparation
10/20/1993EP0566066A1 Antigens of human non-small lung carcinoma
10/20/1993EP0565626A1 Fusions of a viral protein and a destructive enzyme
10/20/1993EP0565590A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE)
10/20/1993EP0529065A4 Receptor-based screening methods for amylin agonists and antagonists
10/20/1993EP0220241B1 Purified protein having angiogenic activity and methods of preparation
10/20/1993CN1077390A Thrombolyzing medicine and its prepn.
10/19/1993US5254463 Method for expression of bovine growth hormone
10/19/1993US5254462 Genetic engineering
10/19/1993CA1323318C Methods for preparing proteins of altered structure
10/19/1993CA1323317C Production of fibroblast growth factor
10/18/1993CA2094177A1 Derivatives of adipogenesis inhibitory factor, their preparation and their use
10/14/1993WO1993020439A1 Compositions and methods for regulating cellular signal transducing systems
10/14/1993WO1993020229A1 ANTIBODIES TO ALPHAvBETA3 INTEGRIN
10/14/1993WO1993020218A1 Synthetic eukaryotic promoters containing two inducible elements
10/14/1993WO1993020215A1 Process for producing recombinant proteins in steptomycetes
10/14/1993WO1993020210A1 Antibodies for treatment and prevention of respiratory syncytial virus infection
10/14/1993WO1993020205A1 ANTI-HBs ANTIBODY GENE AND EXPRESSION PLASMID THEREOF
10/14/1993WO1993020201A1 GAP-ASSOCIATED PROTEIN p190 AND TRANSDUCTION
10/14/1993WO1993020199A1 Human gonadotropin receptor (fsh receptor)
10/14/1993WO1993020197A1 Stem cell proliferation factor
10/14/1993WO1993020196A1 Cloning, expression and uses of a novel secreted protein, f-spondin
10/14/1993WO1993020188A1 Process and culture medium for the production of cells infected by a multiple sclerosis associated virus
10/14/1993WO1993020187A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
10/14/1993WO1993020182A1 Micro-organisms, preparation method therefor and uses thereof
10/14/1993WO1993020093A1 Hybrid human/porcine factor viii
10/14/1993WO1993019785A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection